Don't have Telegram yet? Try it now!
https://zedie.wordpress.com/2013/07/08/novartis-announces-secukinumab-ain457-demonstrated-superiority-to-enbrel-in-head-to-head-phase-iii-psoriasis-study/
Novartis announces secukinumab (AIN457) demonstrated superiority to EnbrelĀ® in head-to-head Phase III psoriasis study